Skip to content
WorkingMomRx
Menu

Head-to-head

Mochi Health vs Hims & Hers

Mochi Health and Hims & Hers both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.

Mochi Health

Ranked #7 · Grade B−

Best for: Parents in one of its covered states who value a hands-on care team over the widest access and the fastest, flattest checkout.

Visit Mochi Health
vs

Hims & Hers

Higher score

Ranked #4 · Grade B+

Best for: Parents who want a recognizable, app-driven brand with a quick async signup and clear semaglutide pricing.

Visit Hims & Hers

The verdict

Higher Rx-Readiness Score: Hims & Hers

Hims & Hers edges out Mochi Health on the Rx-Readiness Score, 87 to 82 (B+ vs B−). Parents who want a recognizable, app-driven brand with a quick async signup and clear semaglutide pricing.

Mochi Health is still a genuine option — a genuinely support-forward program with a strong care team and fair pricing — but limited state coverage and tiered pricing make it a slower, narrower fit for a quick nationwide decision. Weigh the six readiness factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.

Mochi Health Hims & Hers
Time to first dose8088
Mochi
Hims
Flat, predictable pricing7884
Mochi
Hims
No-video (async) intake8090
Mochi
Hims
Nationwide access6690
Mochi
Hims
Both molecules on one plan8678
Mochi
Hims
Easy off-ramp8286
Mochi
Hims

Price, access & features

DetailMochi HealthHims & Hers
Rx-Readiness Score82/100 · B−87/100 · B+
Overall rank#7#4
Semaglutide$138/mo$199/mo
Tirzepatide$238/moNot disclosed
Coverage15 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Mochi Health

Ranked #7 · Grade B−

What we like

  • Strong, responsive care team — helpful if you want a human in the loop
  • Reasonable pricing on both molecules
  • Clear onboarding with real clinician involvement

The caveats

  • Available in roughly 15 states — not nationwide
  • Tiered pricing can move as your plan changes
  • Compounded only — no brand or oral route

Hims & Hers

Ranked #4 · Grade B+

What we like

  • Slick app-first experience with a fast, mostly async intake
  • Flat, posted semaglutide pricing and nationwide coverage
  • Well-known operator with a mature support stack

The caveats

  • Tirzepatide pricing isn't consistently disclosed up front
  • Compounded only — no brand or oral route
  • Upsells across a broad catalog can add noise to a simple decision

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing Mochi Health and Hims & Hers against other providers on our shortlist.

Or browse the full comparison hub.